LUR.F LUXBRIGHT AB

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
0.0100 EUR
Close of Oct 16, 2026
0.2000 5.44
Market cap
EUR 24.2K
P/E
-
P/B
0.50x
ROE
-72.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is LUR.F undervalued?

Graham number

The Graham number of LUXBRIGHT AB cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

LUXBRIGHT AB fundamental analysis

No fundamental analysis for LUXBRIGHT AB yet.

LUXBRIGHT AB stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About LUXBRIGHT AB

Luxbright AB (publ), a technology company, develops, manufactures, and sells microfocus x-ray tubes and sources for industrial and non-destructive testing applications worldwide. It also provides Luxbright IX1, an integrated x-ray source product; Luxbright MF1, an integrated microfocus x-ray tubes; and custom-made x-ray tubes. Luxbright AB (publ) was incorporated in 2012 and is headquartered in Västra Frölunda, Sweden.

Full company profile